Long-term results of Nivolumab + Cabozantinib in RCC

Published Date: 08 Mar 2023

The combination of first-line nivolumab and cabozantinib continues to outperform sunitinib in the treatment of patients with advanced renal cell carcinoma (RCC).

Read Full News

Latest News

The next great performance booster for athletes? Sleep

When we think of elite athletes, we generally think of people who are at the top of their game physically.

Ablation reduces stroke risk for atrial fibrillation and may remove need for some types of blood thinners

A minimally invasive heart procedure to correct irregular heart rhythms called catheter ablation may reduce the risk of stroke enough that some patients can discontinue blood thinners, according to a preliminary late-breaking ...

Earlier blood transfusion may reduce heart failure, arrhythmia in adults with heart disease

An earlier blood transfusion—done when hemoglobin levels were higher—after major general or vascular surgery among people with heart disease was associated with a lower risk of some complications but not the most severe ...

Preparing for a tough exam? A tough gym workout could help with your studies

A new study by researchers at Coventry University has found a high-intensity gym workout appears to increase your ability to focus, remember and process information in your brain.

Frankenstein: Could an assembled body ever breathe, bleed or think? Anatomists explain

Frankenstein's creature is coming back to life—again. As Guillermo del Toro's new adaptation of Mary Shelley's gothic masterpiece airs on Netflix, we provide an anatomist's perspective of her tale of reanimation. Could ...

Biomaterial vaccines could make implanted orthopedic devices safer

Patients with implanted medical devices like orthopedic joint replacements, pacemakers, and artificial heart valves run a small but significant risk that these devices get infected with bacterial pathogens. This starts them ...

Todays Updates

Verekitug's Quarterly Dosing Cuts Asthma Burden, With Michael Wechsler, MD Michael Wechsler, MD, MSc

Wechsler discusses why less frequent dosing matters to patients with severe asthma, plus VALIANT's safety profile and what's next for the field.

Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD

Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD

Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations

Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations

FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis Marco Meglio

Adults with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive now have a second self-administration option for the complement inhibitor zilucoplan.

Levacetylleucine Shows Sustained Benefit at 3 Years in Niemann-Pick Disease Marco Meglio

Three-year extension data from the phase 3 IB1001-301 trial show levacetylleucine slowed disease progression in both adults and children with Niemann-Pick disease type C.

Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era

Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era

Todays Updates

Verekitug's Quarterly Dosing Cuts Asthma Burden, With Michael Wechsler, MD Michael Wechsler, MD, MSc

Wechsler discusses why less frequent dosing matters to patients with severe asthma, plus VALIANT's safety profile and what's next for the field.

Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD

Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD

Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations

Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations

FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis Marco Meglio

Adults with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive now have a second self-administration option for the complement inhibitor zilucoplan.

Levacetylleucine Shows Sustained Benefit at 3 Years in Niemann-Pick Disease Marco Meglio

Three-year extension data from the phase 3 IB1001-301 trial show levacetylleucine slowed disease progression in both adults and children with Niemann-Pick disease type C.

Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era

Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era

Latest News

When we think of elite athletes, we generally think of people who are at the top of their game physically.

A minimally invasive heart procedure to correct irregular heart rhythms called catheter ablation may reduce the risk of stroke enough that some patients can discontinue blood thinners, according to a preliminary late-breaking ...

An earlier blood transfusion—done when hemoglobin levels were higher—after major general or vascular surgery among people with heart disease was associated with a lower risk of some complications but not the most severe ...

A new study by researchers at Coventry University has found a high-intensity gym workout appears to increase your ability to focus, remember and process information in your brain.

Frankenstein's creature is coming back to life—again. As Guillermo del Toro's new adaptation of Mary Shelley's gothic masterpiece airs on Netflix, we provide an anatomist's perspective of her tale of reanimation. Could ...

Patients with implanted medical devices like orthopedic joint replacements, pacemakers, and artificial heart valves run a small but significant risk that these devices get infected with bacterial pathogens. This starts them ...

News All Time

How's your hydration? A new tool from researchers helps athletes find out

Researchers at the Korey Stringer Institute (KSI) in the College of Agriculture, Health and Natural Resources (CAHNR) have created an open-access document to help athletes, coaches, and parents understand the latest research ...

From monkey glands to 'young blood': The long, strange history of chasing immortality through transplants

When Russian president Vladimir Putin visited Beijing in September 2025, he told Chinese leader Xi Jinping that repeated organ transplants might make a person "get younger" and even live to 150. The remark was widely dismissed ...

Sentinel lymph node biopsy noninferior to lymphadenectomy in cervical cancer

For patients with early-stage cervical cancer, sentinel lymph node biopsy alone is noninferior to lymphadenectomy with respect to disease-free survival, according to a study published online Oct. 15 in the New England Journal ...

Gender equality universally linked to physical capacity

Fitness among young adults varies widely from one country to another, and is strongly associated with both socioeconomic development and gender equality, a new study from Karolinska Institutet published in the Journal of ...

Abnormal cell 'conversations' drive chronic lung-transplant rejection, research reveals

More than 50% of lung-transplant recipients experience a rejection of their new lung within five years of receiving it, yet the reason why this is such a prevalent complication has remained a medical mystery.

Fewer women receive lung transplants despite policy changes, study finds

New research from UCLA Health reveals that women continue to face barriers in accessing lung transplants compared to men, despite recent national policy changes aimed at making organ distribution more equitable.

How is radiation therapy portrayed in art?

Because patient perceptions of radiation can influence their willingness to receive it as treatment, researchers recently examined how radiation therapy is represented in different forms of art.

Infrared sauna may hold benefits for team-sport athletes

A study conducted by the Faculty of Sport and Health Sciences at the University of Jyväskylä, Finland, suggests that using an infrared sauna after exercise can speed up recovery and support performance in team-sport athletes. ...

LeBron James will be the first NBA player to reach 23 seasons. How is he still one of the best?

A common saying in sport is: "Father Time is undefeated."

Physical activity raises daily calorie burn without conserving energy used elsewhere, study finds

The effects of physical activity don't stop when the movement does. In a new study published in the Proceedings of the National Academy of Sciences, Virginia Tech researchers, in collaboration with researchers at the University ...

Rising demands, rising performance: Australian Football League Women's players push limits in finals season

As the Australian Football League Women's (AFLW) finals edge closer, players across the league are preparing to push their limits. Now, new research from the University of South Australia shows that AFLW players are pushing ...

Minimally invasive surgery may improve outcomes in severe stroke

Minimally invasive endoscopic surgery may be an effective and safe treatment for patients with intracerebral hemorrhage, the most severe type of stroke, according to results from a recent clinical trial published in JAMA ...

Could your walk be a signal about your ability to win a fight?

Humans have been fighting each other since the earliest stages of our species' history.

Built-in backup system helps muscles counteract fatigue

When you're running up stairs or out on a jog, your muscles eventually start to feel heavy and weak. That's fatigue setting in, a sign that the muscles' energy reserves are becoming depleted. But a team of researchers led ...

GPS technology reveals that football practices can be up to 40% more demanding than games

Until recently, there has been little data available on how much effort football players exert in games versus practices, which position groups run the most or how to balance loads in practice to best meet the needs of game ...

The exercise paradox: Why workouts aren't great for weight loss but useful for maintaining a healthy body weight

The basic principle of weight loss is straightforward: if you consume fewer calories than you burn, you'll lose weight. In practice though, this isn't usually so easy or simple.

Recommended News For You

Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

AZD0486 Shows Good Efficacy in Relapsed/Refractory Follicular Lymphoma

Artificial intelligence is assisting in the earlier detection and treatment of breast cancer.

US Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order

Recommended Articles For You

Liquid Biopsies in Hematology: A Window into the Disease 

Tissue Reconstruction After Extensive Cancer Surgery: Advances, Challenges, and Clinical Considerations 

Learning from Uncommon Inherited Bleeding Disorder Presentations 

Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A prostate cancer risk prediction algorithm could help target men at highest risk

2.

Guideline on management of early-stage non-small cell lung cancer released

3.

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

4.

Adding cell-based vaccine to liver cancer therapy can slow cancer progression

5.

Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.

1.

Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense

2.

Navigating the Complexities of Melanoma Staging: A Comprehensive Guide

3.

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies

4.

Mast Cell-Tumor Cell Interactions in OSCC: Genetic and microRNA Insights

5.

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

3.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot